受强制性开放获取政策约束的文章 - Michael C Kann了解详情
无法在其他位置公开访问的文章：2 篇
CAR T cell killing requires the IFNγR pathway in solid but not liquid tumours
RC Larson, MC Kann, SR Bailey, NJ Haradhvala, PM Llopis, AA Bouffard, ...
Nature 604 (7906), 563-570, 2022
强制性开放获取政策： US National Institutes of Health, Damon Runyon Cancer Research Foundation
Comparative analysis of Bcl-2 family protein overexpression in CAR T cells alone and in combination with BH3 mimetics
F Korell, ML Olson, D Salas-Benito, MB Leick, RC Larson, A Bouffard, ...
Science Translational Medicine 16 (750), eadk7640, 2024
强制性开放获取政策： Swiss National Science Foundation
可在其他位置公开访问的文章：11 篇
Reversible ON-and OFF-switch chimeric antigen receptors controlled by lenalidomide
M Jan, I Scarfò, RC Larson, A Walker, A Schmidts, AA Guirguis, JA Gasser, ...
Science translational medicine 13 (575), eabb6295, 2021
强制性开放获取政策： US National Institutes of Health, Howard Hughes Medical Institute, V …
Distinct cellular dynamics associated with response to CAR-T therapy for refractory B cell lymphoma
NJ Haradhvala, MB Leick, K Maurer, SH Gohil, RC Larson, N Yao, ...
Nature medicine 28 (9), 1848-1859, 2022
强制性开放获取政策： US National Institutes of Health
Non-cleavable hinge enhances avidity and expansion of CAR-T cells for acute myeloid leukemia
MB Leick, H Silva, I Scarfò, R Larson, BD Choi, AA Bouffard, K Gallagher, ...
Cancer cell 40 (5), 494-508. e5, 2022
强制性开放获取政策： Swiss National Science Foundation, US National Institutes of Health …
Blockade or deletion of IFNγ reduces macrophage activation without compromising CAR T-cell function in hematologic malignancies
SR Bailey, S Vatsa, RC Larson, AA Bouffard, I Scarfò, MC Kann, ...
Blood Cancer Discovery 3 (2), 136-153, 2022
强制性开放获取政策： US National Institutes of Health, Lymphoma Research Foundation, USA, Damon …
Tandem chimeric antigen receptor (CAR) T cells targeting EGFRvIII and IL-13Rα2 are effective against heterogeneous glioblastoma
A Schmidts, AA Srivastava, R Ramapriyan, SR Bailey, AA Bouffard, ...
Neuro-Oncology Advances 5 (1), vdac185, 2023
强制性开放获取政策： US National Institutes of Health, Lymphoma Research Foundation, USA, Damon …
Cell-based artificial APC resistant to lentiviral transduction for efficient generation of CAR-T cells from various cell sources
A Schmidts, LC Marsh, AA Srivastava, AA Bouffard, AC Boroughs, I Scarfò, ...
Journal for immunotherapy of cancer 8 (2), 2020
强制性开放获取政策： US National Institutes of Health, Lymphoma Research Foundation, USA
Mesothelin CAR T Cells Secreting Anti-FAP/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its Stroma
M Wehrli, S Guinn, F Birocchi, A Kuo, Y Sun, RC Larson, AJ Almazan, ...
Clinical Cancer Research 30 (9), 1859-1877, 2024
强制性开放获取政策： Swiss National Science Foundation
Anti-TACI single and dual-targeting CAR T cells overcome BCMA antigen loss in multiple myeloma
RC Larson, MC Kann, C Graham, CW Mount, AP Castano, WH Lee, ...
Nature Communications 14 (1), 7509, 2023
强制性开放获取政策： US National Institutes of Health, Damon Runyon Cancer Research Foundation
Stealth transgenes enable CAR-T cells to evade host immune responses
K Grauwet, T Berger, MC Kann, H Silva, R Larson, MB Leick, SR Bailey, ...
Journal for Immunotherapy of Cancer 12 (5), 2024
强制性开放获取政策： US National Institutes of Health
Neuro-Oncology Advances
A Schmidts, AA Srivastava, R Ramapriyan, SR Bailey, AA Bouffard, ...
强制性开放获取政策： US National Institutes of Health, Lymphoma Research Foundation, USA, Damon …
221 CRISPR screen identifies loss of IFNγR signaling and downstream adhesion as a resistance mechanism to CAR T-cell cytotoxicity in solid but not liquid tumors
R Larson, M Kann, S Bailey, N Haradhvala, K Stewart, A Bouffard, I Scarfo, ...
Journal for ImmunoTherapy of Cancer 9 (Suppl 2), 2021
强制性开放获取政策： US National Institutes of Health, Damon Runyon Cancer Research Foundation
出版信息和资助信息由计算机程序自动确定